Publications by authors named "Antonia Llunell"
SARS-CoV-2 and Legionella pneumophila coinfection.
Enferm Infecc Microbiol Clin (Engl Ed)
December 2022
The impact of blood eosinophilia in chronic obstructive pulmonary disease (COPD) remains controversial.To evaluate the prevalence and stability of a high level of blood eosinophils (≥300 cells·μL) and its relationship to outcomes, we determined blood eosinophils at baseline and over 2 years in 424 COPD patients (forced expiratory volume in 1 s (FEV) 60% predicted) and 67 smokers without COPD from the CHAIN cohort, and in 308 COPD patients (FEV 60% predicted) in the BODE cohort. We related eosinophil levels to exacerbations and survival using Cox hazard analysis.
View Article and Find Full Text PDFDifferential Effect of Modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for Symptoms Evaluation Within the New GOLD Staging and Mortality in COPD.
Chest
July 2015
Article Synopsis
- - The study aimed to evaluate how well the COPD Assessment Test (CAT), Clinical COPD Questionnaire (CCQ), and Modified Medical Research Council (mMRC) dyspnea scores predict mortality in patients with Chronic Obstructive Pulmonary Disease (COPD).
- - Researchers analyzed data from 768 COPD patients over an average follow-up of 38 months, finding that higher scores on all three assessments were linked to increased mortality.
- - Although the CAT and CCQ have similar predictive abilities for all-cause mortality, they were not as effective as the mMRC dyspnea scores, leading to suggestions for new scoring thresholds for better risk assessments.
Rationale: Little is known about the longitudinal changes associated with using the 2013 update of the multidimensional GOLD strategy for chronic obstructive pulmonary disease (COPD).
Objective: To determine the COPD patient distribution of the new GOLD proposal and evaluate how this classification changes over one year compared with the previous GOLD staging based on spirometry only.
Methods: We analyzed data from the CHAIN study, a multicenter observational Spanish cohort of COPD patients who are monitored annually.
Background: When a disorder is as prevalent as sleep apnea-hypopnea syndrome (SAHS), different medical levels and approaches should be involved in facilitating the diagnosis, at least, of patients with symptoms that disrupt social or working life, and of risk groups such as professional drivers. We sought to analyze the degree of concordance between management and treatment decisions for SAHS patients at sleep reference centers (RCs) and at non-RCs (NRCs).
Materials And Methods: Eighty-eight consecutive patients with suspected SAHS were referred by family doctors to the NRC.